Article Details

Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery

Retrieved on: 2025-06-13 11:43:27

Tags for this article:

Click the tags to see associated articles and topics

Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery. View article details on hiswai:

Excerpt

Parallel Bio's platform combines lymph-node organoids with AI and robotics to replicate the human immune system at scale across diverse populations.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo